Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Can the Apgar Score be Used for International Comparisons of Newborn Health?

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023698%3A_____%2F17%3AN0000023" target="_blank" >RIV/00023698:_____/17:N0000023 - isvavai.cz</a>

  • Výsledek na webu

    <a href="http://dx.doi.org/10.1111/ppe.12368" target="_blank" >http://dx.doi.org/10.1111/ppe.12368</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/ppe.12368" target="_blank" >10.1111/ppe.12368</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Can the Apgar Score be Used for International Comparisons of Newborn Health?

  • Popis výsledku v původním jazyce

    The Apgar score has been shown to be predictive of neonatal mortality in clinical and population studies, but has not been used for international comparisons. We examined population-level distributions in Apgar scores and associations with neonatal mortality in Europe. Methods: Aggregate data on the 5 minute Apgar score for live births and neonatal mortality rates from countries participating in the Euro-Peristat project in 2004 and 2010 were analysed. Country level associations between the Apgar score and neonatal mortality were assessed using the Spearman rank correlation coefficient. Results: Twenty-three countries or regions provided data on Apgar at 5 minutes, covering 2 183 472 live births. Scores < 7 ranged from 0.3% to 2.4% across countries in 2004 and 2010 and were correlated over time (rho = 0.88, P < 0.01). There were large differences in healthy baby scores: scores of 10 ranged from 8.8% to 92.7% whereas scores of 9 or 10 ranged from 72.9% to 96.8%. Countries more likely to score 10 s, as opposed to 9 s, for healthy babies had lower proportions of Apgar < 7 (rho = -0.43, P = 0.04). Neonatal mortality rates were weakly correlated with Apgar score < 7 (rho = -0.06, P = 0.61), but differences over time in these two indicators were correlated (rho = 0.56, P = 0.02). Conclusions: Large variations in the distribution of Apgar scores likely due to national scoring practices make the Apgar score an unsuitable indicator for benchmarking newborn health across countries. However, country-level trends over time in the Apgar score may reflect real changes and merit further investigation.

  • Název v anglickém jazyce

    Can the Apgar Score be Used for International Comparisons of Newborn Health?

  • Popis výsledku anglicky

    The Apgar score has been shown to be predictive of neonatal mortality in clinical and population studies, but has not been used for international comparisons. We examined population-level distributions in Apgar scores and associations with neonatal mortality in Europe. Methods: Aggregate data on the 5 minute Apgar score for live births and neonatal mortality rates from countries participating in the Euro-Peristat project in 2004 and 2010 were analysed. Country level associations between the Apgar score and neonatal mortality were assessed using the Spearman rank correlation coefficient. Results: Twenty-three countries or regions provided data on Apgar at 5 minutes, covering 2 183 472 live births. Scores < 7 ranged from 0.3% to 2.4% across countries in 2004 and 2010 and were correlated over time (rho = 0.88, P < 0.01). There were large differences in healthy baby scores: scores of 10 ranged from 8.8% to 92.7% whereas scores of 9 or 10 ranged from 72.9% to 96.8%. Countries more likely to score 10 s, as opposed to 9 s, for healthy babies had lower proportions of Apgar < 7 (rho = -0.43, P = 0.04). Neonatal mortality rates were weakly correlated with Apgar score < 7 (rho = -0.06, P = 0.61), but differences over time in these two indicators were correlated (rho = 0.56, P = 0.02). Conclusions: Large variations in the distribution of Apgar scores likely due to national scoring practices make the Apgar score an unsuitable indicator for benchmarking newborn health across countries. However, country-level trends over time in the Apgar score may reflect real changes and merit further investigation.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30209 - Paediatrics

Návaznosti výsledku

  • Projekt

  • Návaznosti

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Ostatní

  • Rok uplatnění

    2017

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Paediatric and Perinatal Epidemiology

  • ISSN

    0269-5022

  • e-ISSN

    1365-3016

  • Svazek periodika

    31

  • Číslo periodika v rámci svazku

    4

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    8

  • Strana od-do

    338-345

  • Kód UT WoS článku

    000405827300013

  • EID výsledku v databázi Scopus

    2-s2.0-85024117633